Abstract
There are a number of cell therapies that are either in clinical trials or moving toward clinical trials, particularly for diseases of the retina. One of the challenges with cell therapies is tracking the status of cells over time. Genetic manipulation can facilitate this, but it can limit the clinical application of the cells. There are a host of fluorophores that have been developed to assess the status of cells, but these molecules tend to be cleared rapidly from cells. There are preclinical strategies that use degradable scaffolds, and we hypothesized that these scaffolds could be used to track the state of cells during preclinical studies. In this work, we explored whether fluorophores could be delivered from simple scaffolds fabricated under extremely harsh conditions, be active upon release, and report on the cells growing on the scaffolds over time. We encapsulated CellROX® Green Reagent, and pHrodo™ Red AM in poly(lactic-co-glycolic acid) (PLGA) scaffolds, showed that they could be delivered over weeks and were still active upon release and taken up by cells. These experiments provide the foundation for using scaffolds to deliver molecules to report on cells.
Similar content being viewed by others
References
Aziz, M., W. L. Yang, and P. Wang. Measurement of phagocytic engulfment of apoptotic cells by macrophages using pHrodo succinimidyl ester. In: Current protocols in immunology Chapter 14:Unit 14.31, edited by Z. Chen. New York: Wiley, 2013.
Bharti, K. Patching the retina with stem cells. Nat. Biotechnol. 36:311–313, 2018.
Bourges, J. L., S. E. Gautier, F. Delie, R. A. Bejjani, J. C. Jeanny, et al. Ocular drug delivery targeting the retina and retinal pigment epithelium using polylactide nanoparticles. Invest. Ophthalmol. Vis. Sci. 44:3562–3569, 2003.
Bramley, T., P. Peeples, J. G. Walt, M. Juhasz, and J. E. Hansen. Impact of vision loss on costs and outcomes in medicare beneficiaries with glaucoma. Arch. Ophthalmol. 126:849–856, 2008.
Carr, A. J., M. J. Smart, C. M. Ramsden, M. B. Powner, L. da Cruz, and P. J. Coffey. Development of human embryonic stem cell therapies for age-related macular degeneration. Trends Neurosci. 36:385–395, 2013.
Chen, Z., and Y. A. Zhang. Cell therapy for macular degeneration–first phase I/II pluripotent stem cell-based clinical trial shows promise. Sci. China Life Sci. 58:119–120, 2015.
da Cruz, L., K. Fynes, O. Georgiadis, J. Kerby, Y. H. Luo, et al. Phase 1 clinical study of an embryonic stem cell-derived retinal pigment epithelium patch in age-related macular degeneration. Nat. Biotechnol. 36:328–337, 2018.
Dai, X., G. Hong, T. Gao, and C. M. Lieber. Mesh nanoelectronics: seamless integration of electronics with tissues. Acc. Chem. Res. 51:309–318, 2018.
Groynom, R., E. Shoffstall, L. S. Wu, R. H. Kramer, and E. B. Lavik. Controlled release of photoswitch drugs by degradable polymer microspheres. J. Drug Target 23:710–715, 2015.
Hafeli, U. O., J. S. Riffle, L. Harris-Shekhawat, A. Carmichael-Baranauskas, F. Mark, et al. Cell uptake and in vitro toxicity of magnetic nanoparticles suitable for drug delivery. Mol. Pharm. 6:1417–1428, 2009.
Hoekstra, M. E., F. E. Dijkgraaf, T. N. Schumacher, and J. C. Rohr. Assessing T lymphocyte function and differentiation by genetically encoded reporter systems. Trends Immunol. 36:392–400, 2015.
Hu, X. B., Y. L. Liu, W. J. Wang, H. W. Zhang, Y. Qin, et al. Biomimetic graphene-based 3D scaffold for long-term cell culture and real-time electrochemical monitoring. Anal. Chem. 90:1136–1141, 2018.
Kador, K. E., and J. L. Goldberg. Scaffolds and stem cells: delivery of cell transplants for retinal degenerations. Expert Rev. Ophthalmol. 7:459–470, 2012.
Kador, K. E., R. B. Montero, P. Venugopalan, J. Hertz, A. N. Zindell, et al. Tissue engineering the retinal ganglion cell nerve fiber layer. Biomaterials 34:4242–4250, 2013.
Kapellos, T. S., L. Taylor, H. Lee, S. A. Cowley, W. S. James, et al. A novel real time imaging platform to quantify macrophage phagocytosis. Biochem. Pharmacol. 116:107–119, 2016.
Khoh-Reiter, S., S. A. Sokolowski, B. Jessen, M. Evans, D. Dalvie, and S. Lu. Contribution of membrane trafficking perturbation to retinal toxicity. Toxicol. Sci. 145:383–395, 2015.
Kim, Y. M., S. J. Kim, R. Tatsunami, H. Yamamura, T. Fukai, and M. Ushio-Fukai. ROS-induced ROS release orchestrated by Nox4, Nox2, and mitochondria in VEGF signaling and angiogenesis. Am. J. Physiol. Cell Physiol. 312:C749–C764, 2017.
Lavik, E., M. H. Kuehn, A. J. Shoffstall, K. Atkins, A. V. Dumitrescu, and Y. H. Kwon. Sustained delivery of timolol maleate for over 90 days by subconjunctival injection. J. Ocul. Pharmacol. Ther. 32:642–649, 2016.
Liu, Y., S. J. Chen, S. Y. Li, L. H. Qu, X. H. Meng, et al. Long-term safety of human retinal progenitor cell transplantation in retinitis pigmentosa patients. Stem Cell Res. Ther. 8:209, 2017.
Liu, Y., and W. Deng. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology. Brain Res. 1638:30–41, 2016.
Madri, J., and S. Williams. Capillary endothelial cell cultures: phenotypic modulation by matrix components. J. Cell Biol. 97:153–165, 1983.
Mazumder, M. A., S. D. Fitzpatrick, B. Muirhead, and H. Sheardown. Cell-adhesive thermogelling PNIPAAm/hyaluronic acid cell delivery hydrogels for potential application as minimally invasive retinal therapeutics. J. Biomed. Mater. Res. A 100:1877–1887, 2012.
Sharma, R., V. Khristov, A. Rising, B. S. Jha, R. Dejene, et al. Clinical-grade stem cell-derived retinal pigment epithelium patch rescues retinal degeneration in rodents and pigs. Sci Transl Med 11:5580, 2019.
Sturesson, C., and J. Carlfors. Incorporation of protein in PLG-microspheres with retention of bioactivity. J. Control Release 67:171–178, 2000.
Tan, Y. S. E., P. J. Shi, C. J. Choo, A. Laude, and W. Y. Yeong. Tissue engineering of retina and Bruch’s membrane: a review of cells, materials and processes. Br. J. Ophthalmol. 102:1182–1187, 2018.
Tang, Z., Y. Zhang, Y. Wang, D. Zhang, B. Shen, et al. Progress of stem/progenitor cell-based therapy for retinal degeneration. J. Transl. Med. 15:99, 2017.
Tochitsky, I., J. Trautman, N. Gallerani, J. G. Malis, and R. H. Kramer. Restoring visual function to the blind retina with a potent, safe and long-lasting photoswitch. Sci. Rep. 7:45487, 2017.
Treharne, A. J., M. C. Grossel, A. J. Lotery, and H. A. Thomson. The chemistry of retinal transplantation: the influence of polymer scaffold properties on retinal cell adhesion and control. Br. J. Ophthalmol. 95:768–773, 2011.
Ueda, T., T. Tamura, and I. Hamachi. In situ construction of protein-based semisynthetic biosensors. ACS Sens. 3:527–539, 2018.
Wang, Y., Q. S. Zang, Z. Liu, Q. Wu, D. Maass, et al. Regulation of VEGF-induced endothelial cell migration by mitochondrial reactive oxygen species. Am. J. Physiol. Cell Physiol. 301:C695–C704, 2011.
Weber, D., B. Torger, K. Richter, M. Nessling, F. Momburg, et al. Interaction of poly(l-lysine)/polysaccharide complex nanoparticles with human vascular endothelial cells. Nanomaterials (Basel, Switzerland) 8:358, 2018.
Wong, W. L., X. Su, X. Li, C. M. Cheung, R. Klein, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet 2:e106–e116, 2014.
Worthington, K. S., L. A. Wiley, E. E. Kaalberg, M. M. Collins, R. F. Mullins, et al. Two-photon polymerization for production of human iPSC-derived retinal cell grafts. Acta Biomater. 55:385–395, 2017.
Yokoyama, C., Y. Sueyoshi, M. Ema, Y. Mori, K. Takaishi, and H. Hisatomi. Induction of oxidative stress by anticancer drugs in the presence and absence of cells. Oncology letters 14:6066–6070, 2017.
Zarbin, M. Cell-based therapy for degenerative retinal disease. Trends Mol. Med. 22:115–134, 2016.
Acknowledgments
This work was supported by a grant from the Steven J. Ryan Initiative for Macular Research and NIH Grant 1R56NS100732-01. Dr. Lavik is an inventor on intellectual property that includes the potential for incorporation of reporter molecules.
Author information
Authors and Affiliations
Corresponding author
Additional information
Associate Editor Jennifer West oversaw the review of this article.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Bolger, M., Groynom, R., Bogie, K. et al. Reporter Scaffolds for Clinically Relevant Cell Transplantation Studies. Ann Biomed Eng 48, 1982–1990 (2020). https://doi.org/10.1007/s10439-019-02393-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10439-019-02393-z